ArticleMicrobiome2025
Members of Lachnospiraceae produce valerate and caproate in response to short-chain fatty acids.
Article in Microbiome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Del immune V and microbiome restructuring in colorectal cancer surgery: a randomized double blind placebo controlled trial.Frontiers in cellular and infection microbiology · 2026Trial
- Type 2 diabetes-associated gut microbial composition and short chain fatty acids differ across the epidemiologic transition in African origin populations.Gut microbes reports · 2027Article
- The effect of pectin supplementation on geriatric individuals with frailty: a randomised placebo-controlled dietary intervention study.GeroScience · 2026Article
- Effects of Dietary Fibers with Different Physicochemical Properties on Intestinal Health and Growth Performance of Meat Rabbits.Animals : an open access journal from MDPI · 2026Article
- The Role ofInternational journal of molecular sciences · 2026Review
- Intracellular acidification by microbiota-derived valeric acid facilitates trans-kingdom ecology limiting Candida parapsilosis colonization.Cell host & microbe · 2026Article
- Soybean-Derived Soluble Fiber Enhances Antimicrobial Proteins in the Mouse Small Intestine via a Tuft Cell-Group 2 Innate Lymphoid Cell Axis.Journal of agricultural and food chemistry · 2026Article
- Phytosynbiotic Containing Double-Layer MicroencapsulatedAnimals : an open access journal from MDPI · 2026Article
- Functional shotgun metagenomic insights into gut microbial pathway and enzyme disruptions linking metabolism, affect, cognition, and suicidal ideation in major depressive disorder.Acta neuropsychiatrica · 2026Article
- Plasma Short-Chain Fatty Acids and Cytokine Profiles in Chronic Kidney Disease: A Potential Pathophysiological Link.International journal of molecular sciences · 2026Article
- Article
- Microbiota-Metabolome Alterations Suggest Pro-Inflammatory Phenotype in Congenital Central Hypoventilation Syndrome.International journal of microbiology · 2026Article
- Circadian rhythm disruption aggravates high-fat diet-induced NAFLD through gut microbiota alterations in mice.Frontiers in microbiology · 2026Article
- Gut microbiota-derived short-chain fatty acids in gallstones: mechanisms and intervention strategies.Frontiers in microbiology · 2026Review
- Effects of processed soybean meal on growth performance and gut microbiome composition in pigs in regular nursery and enterotoxigenicTranslational animal science · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe human gut microbiota ferments carbohydrates to produce metabolites that mediate beneficial community functions. While the production of the short-chain fatty acids (SCFAs) acetate, propionate, and butyrate is well characterized, how valerate and caproate are produced has remained enigmatic.
resultsHere, we characterize the production of valerate and caproate by the gut microbiota. In a continuous culture model of a defined gut bacterial community, we observed that valerate took longer to reach physiological levels than acetate, propionate, or butyrate and correlated with Lachnospiraceae. This led us to test valerate and caproate production by members of Lachnospiraceae. While tested Lachnospiraceae isolates produced low levels of valerate and caproate at baseline, physiological concentrations of SCFAs activated valerate and caproate production in a species-specific manner. Furthermore, providing isotopically labelled SCFAs revealed that isolates of Anaerostipes hadrus and Coprococcus comes, which are members of Lachnospiraceae, directly incorporate exogenous acetate, propionate, and butyrate into valerate and caproate in a manner consistent with the reverse β-oxidation pathway. Therefore, we examined this pathway in Lachnospiraceae and found that Lachnospiraceae spp. encode different copy numbers and variants of the enzyme acetyl-CoA acetyltransferase (ThlA). ThlA performs the first step in reverse β-oxidation by condensing acyl-CoA molecules. We demonstrate that tested Lachnospiraceae ThlA protein variants consume propionyl-CoA and acetyl-CoA substrates consistent with valerate production. Coprococcus comes, the only tested species to produce caproate, encodes a second ThlA protein with increased activity on butyryl-CoA. In human fecal samples, multiple genera of Lachnospiraceae correlate with butyrate, while Coprococcus also correlates with caproate levels.
conclusionsThese findings reveal a role of certain members of the Lachnospiraceae as prominent producers of valerate and caproate within human microbiomes through the reverse β-oxidation pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.